AIM: To provide information on the extent to which type 2 diabetes more likely induced by statins affects the risk of macrovascular complications compared to diabetes unlikely induced by statins. METHODS: The 84,828 residents in the Italian Lombardy Region who were newly treated with statins between 2003 and 2005 were followed from the index statin prescription until 2009 (step-1 follow-up) to identify those starting antidiabetic therapy. The proportion of days of follow-up covered by statins measured adherence with statins. Cohort members who experienced diabetes were 1:3 matched with those who did not developed diabetes for gender, age and previous adherence with statin treatment. The 3321 diabetic - non-diabetic sets, were followed from the initial antidiabetic therapy until 2012 (step-2 follow-up) to estimate the hazard ratio (HR), and 95% Confidence Interval (CI), for macrovascular complications (proportional hazard models) associated with diabetes separately in each category of adherence with statins. RESULTS: During the step-1 follow-up, the risk of new-onset diabetes increased progressively with increasing adherence with statins. During the step-2 follow-up, the risk of macrovascular complications associated with diabetes decreased progressively from 1.70 (1.18-2.44), 1.41 (1.17-1.70), 1.30 (1.07-1.57) until 1.10 (0.40-2.80) as adherence with statins during the step-1 follow-up increased. CONCLUSIONS: Type 2 diabetes lost its association with increasing macrovascular risk when previous adherence with statins was very high, and thus the chance of its induction by the drug greater. Statin-dependent type 2 diabetes might be prognostically less adverse than diabetes unlikely induced by statins.

Corrao, G., Monzio Compagnoni, M., Rea, F., Merlino, L., Catapano, A., & Mancia, G. (2017). Clinical significance of diabetes likely induced by statins: Evidence from a large population-based cohort. DIABETES RESEARCH AND CLINICAL PRACTICE, 133, 60-68 [10.1016/j.diabres.2017.08.008].

Clinical significance of diabetes likely induced by statins: Evidence from a large population-based cohort

Corrao, G
;
Monzio Compagnoni, M;Rea, F;Mancia, G
2017

Abstract

AIM: To provide information on the extent to which type 2 diabetes more likely induced by statins affects the risk of macrovascular complications compared to diabetes unlikely induced by statins. METHODS: The 84,828 residents in the Italian Lombardy Region who were newly treated with statins between 2003 and 2005 were followed from the index statin prescription until 2009 (step-1 follow-up) to identify those starting antidiabetic therapy. The proportion of days of follow-up covered by statins measured adherence with statins. Cohort members who experienced diabetes were 1:3 matched with those who did not developed diabetes for gender, age and previous adherence with statin treatment. The 3321 diabetic - non-diabetic sets, were followed from the initial antidiabetic therapy until 2012 (step-2 follow-up) to estimate the hazard ratio (HR), and 95% Confidence Interval (CI), for macrovascular complications (proportional hazard models) associated with diabetes separately in each category of adherence with statins. RESULTS: During the step-1 follow-up, the risk of new-onset diabetes increased progressively with increasing adherence with statins. During the step-2 follow-up, the risk of macrovascular complications associated with diabetes decreased progressively from 1.70 (1.18-2.44), 1.41 (1.17-1.70), 1.30 (1.07-1.57) until 1.10 (0.40-2.80) as adherence with statins during the step-1 follow-up increased. CONCLUSIONS: Type 2 diabetes lost its association with increasing macrovascular risk when previous adherence with statins was very high, and thus the chance of its induction by the drug greater. Statin-dependent type 2 diabetes might be prognostically less adverse than diabetes unlikely induced by statins.
Articolo in rivista - Articolo scientifico
Adherence; Cohort study; Healthcare utilization database; Macrovascular outcomes; Statins; Type 2 diabetes; Aged; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Retrospective Studies; Internal Medicine; Endocrinology, Diabetes and Metabolism; Endocrinology
English
60
68
9
Corrao, G., Monzio Compagnoni, M., Rea, F., Merlino, L., Catapano, A., & Mancia, G. (2017). Clinical significance of diabetes likely induced by statins: Evidence from a large population-based cohort. DIABETES RESEARCH AND CLINICAL PRACTICE, 133, 60-68 [10.1016/j.diabres.2017.08.008].
Corrao, G; Monzio Compagnoni, M; Rea, F; Merlino, L; Catapano, A; Mancia, G
File in questo prodotto:
File Dimensione Formato  
Clinical significance of diabetes likely induced by statins. Evidence from a large population-based cohort.pdf

Solo gestori archivio

Tipologia di allegato: Author’s Accepted Manuscript, AAM (Post-print)
Dimensione 915.49 kB
Formato Adobe PDF
915.49 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/205671
Citazioni
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 12
Social impact